Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects
Clinical trial NCT02235961 · COMPLETED
Trial details
- NCT number
- NCT02235961
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-04
- Primary completion
- 2016-07-06
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.